MOC, a unit of Cellcure Cancer Center Pvt Ltd, is planning to utilise the newly-infused capital to expand across India in next 18 months, the company said in a statement.
It, however, did not disclose how much stake the private equity fund sponsored by Tata Capital Ltd will invest in the cancer care chain.
At present, MOC operates 16 state-of-the-art cancer treatment facilities in 10 cities of Maharashtra and Madhya Pradesh under the leadership of 19 medical oncologists. It was founded in 2018 by four Medical Oncologists - Dr Ashish Joshi, Dr Vashishth Maniar, Dr Pritam Kalaskar and Dr Kshitij Joshi.
Partner at Tata Capital Healthcare Fund, Mr Vamesh Chovatia, Partner at Tata Capital Healthcare Fund said “MOC is an exciting addition in our healthcare and life science portfolio. The philosophy and mission of MOC, to provide high quality care at affordable price points aligned with our objective of financing such scalable and profitable business models.
TCHF is a growth-oriented private equity fund focused on the healthcare and lifesciences sector in India. TCHF has raised nearly $200 million across two funds -- TCHF I (2012) and TCHF II (2022). Across both the funds, TCHF has invested in 12 companies, and has successfully exited 5 companies thus far.
Every year approximately 1.5 million people get diagnosed with cancer in India and at any given time there are additional 2.5-3 million cancer patients who are undergoing treatment. Large number of these patients need chemotherapy, immunotherapy, and the majority need to consult a medical oncologist during their treatment journey. MOC addresses this unmet need with community daycare centers.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app